Mid-tier fund specializing in technology and healthcare investments across North America and Europe. Engaged in both early and growth-stage opportunities, the firm has completed over 30 deals with notable exits in the public markets. Emphasizes a contrarian investment style, leveraging extensive industry expertise to identify undervalued assets. Recognized for fostering strong partnerships with management teams to drive value creation.